Clinical trials: Placenta Accreta Spectrum
Placenta Accreta, Unspecified Trimester
Association of Ultrasonographic Parameters With FIGO Clinical Grading System for Placenta Accreta Spectrum
To evaluate the association of ultrasonographic parameters suggestive of placenta accreta with intraoperative clinical diagnosis of placenta accreta according to the the clinical grading system for placenta accreta spectrum (PAS)…
- Trial name
- NCT04801706
- Testing
- Ultrasound
- Volunteers
- 158 people, healthy volunteers welcome
- Sponsor
- Assiut University
Placenta Accreta
Risk Factors for Occurrence of Placenta Accrete Spectrum Following Primary Cesarean Delivery
This study will be conducted on a group of patients undergoing repeat elective caesarean delivery attending at Mansoura university hospital.
- Trial name
- NCT04264169
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Mansoura University Hospital
Maternal; Procedure
Total Placenta Previa Associated With the Placenta Accreta Spectrum.
To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.
- Trial name
- PAS (NCT06219564)
- Testing
- Peripartum total abdominal hysterectomy (p-TAH), Cesarean Section (C/S), Neonatal mortality
- Where
- Turkey (Türkiye)
- Volunteers
- 277 people, healthy volunteers welcome
- Sponsor
- Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Bladder Injury, Complications; Cesarean Section
Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery
Part1:The healthy pregnant women with previous operative deliveries admitted for elective C-section will be counselled and conditioned informed consent will be taken to be included in either study group if dense pelvic adhesions…
- Conditions
- Bladder Injury, Complications; Cesarean Section, Adhesions Pelvic
- Trial name
- NCT04302545
- Testing
- Cystoinflation
- Where
- Pakistan
- Volunteers
- 564 people, healthy volunteers welcome
- Sponsor
- Shazia Saaqib
Placenta Accreta Spectrum
Accuracy of Three /Four-dimensional Ultrasound in Diagnosing Placenta Accreta Spectrum
The placenta accreta spectrum (PAS) which includes accreta, increta, and percreta represents a significant obstetric challenge. PAS complicates as many as 1 per 500 pregnancies and this risk is increased with prior cesarean…
- Trial name
- NCT04229953
- Testing
- US scan with 3D/4D VRU software
- Volunteers
- 113 people
- Sponsor
- Hatem AbuHashim
Placenta Accreta
Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum
This study evaluates the clinical implementation of intra-operative topographic classification system for PAS. In addition to a standard of care risk stratification prenatal ultrasound for patients with a risk of PAS, this study…
- Trial name
- NCT07283042
- Testing
- Total Hysterectomy, Modified subtotal hysterectomy, One-Step Conservative Surgery
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- University of California, Los Angeles
Placenta Accreta, Third Trimester
Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
We planed to evaluate soluble the triggering receptors expressed on myeloid cell-1 (s TREM-1) levels in serum of pregnant women diagnosed with placenta accreta spectrum and compare it with healthy pregnant women's s TREM-1 serum…
- Trial name
- NCT05376410
- Where
- Turkey (Türkiye)
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Necmettin Erbakan University
Placenta Accreta Spectrum
Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study
Placenta accreta spectrum (PAS) is a serious pregnancy complication in which the placenta grows abnormally into the uterine wall.
- Trial name
- SAGA-PAS (NCT07406841)
- Testing
- spinal anesthesia, General Anesthesia
- Volunteers
- 50 people
- Sponsor
- Gaziantep City Hospital
Placenta Accreta
3D Placental Volume in Placenta Accreta
Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with…
- Trial name
- NCT06755047
- Testing
- 3D Ultrasound, 2D ultrasound
- Where
- Egypt
- Volunteers
- 106 people, healthy volunteers welcome
- Sponsor
- Assiut University
Placenta Accreta
Evaluation of Planned Conservative Surgical Management of Placenta Accreta Spectrum in Women's Health Center, Assiut University Hospital
In recent years, with the application of an abdominal artery balloon and the improvement of surgical techniques, efforts are made to preserve the uterus for patients PAS.
- Trial name
- NCT06712576
- Volunteers
- 150 people
- Sponsor
- Assiut University
Placenta Accreta Spectrum, Placenta Accreta / Percreta
Relaxin and Placental Volume in Placenta Accreta Spectrum
This retrospective case-control study investigated the potential role of circulating relaxin levels and estimated placental volumes (EPV) in the pathogenesis and diagnosis of placenta accreta spectrum (PAS) disorders.
- Trial name
- NCT06808165
- Testing
- relaxin
- Where
- Turkey (Türkiye)
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Başakşehir Çam & Sakura City Hospital
Urologic Injuries, Urodynamic Changes
Urodynamic Changes Following Bladder Injury
This study is a unique one as it si done for first time to all patients following bladder injury in PAS surgery. Bladder function will be assessed by urodynamic study.
- Conditions
- Urologic Injuries, Urodynamic Changes, Bladder Dysfunction
- Trial name
- Uro-PAS (NCT04835766)
- Testing
- Urodynamic study
- Where
- Egypt
- Volunteers
- 120 people
- Sponsor
- Tanta University
Placenta Accreta
Placenta Accreta Spectrum Disorder Conservative Managment Versus Hysterectomy Prospective Analysis
The aim of this study is to identify risk factors associated with performing cesarean hysterectomy versus conservative management in patients with placenta accreta spectrum (PAS).
- Trial name
- NCT06105034
- Testing
- interventional techniques, the severity of placental invasion, and various placental positions and suture techniques
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- Nourhan Elsadany
Placenta Accrete Spectrum
The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion
To evaluate the correlation between preoperative ultrasound imaging findings by 3D Color Doppler Ultrasound and the intraoperative severity of Placenta Accreta Spectrum (PAS) disorders, in order to assess the diagnostic accuracy…
- Trial name
- NCT07250412
- Testing
- Cesarian section
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Sohag University
Placenta Accreta Spectrum
Blood Components Changes by Using of Ringer's Lactated as Detergent In Autologous Blood Cell Transfusion
Placenta accreta spectrum (PAS) disorders are associated with increased maternal morbidity and mortality related to life-threatening hemorrhage, and greater potential need for blood transfusion.
- Trial name
- NCT04927988
- Testing
- Ringer's Lactated
- Where
- China
- Sponsor
- Maternal and Child Health Hospital of Foshan
Placenta Accreta
Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum
Vessels ligation have been used as a part of conservative management in treatment of placenta accrete spectrum to decrease blood loss as uterine artery ligation and internal iliac artery ligation.
- Trial name
- NCT04593303
- Testing
- Internal iliac artery ligation with cervicoisthmic compression suture, Cervicoisthmic compression suture without Internal iliac artery ligation
- Where
- Egypt
- Volunteers
- 42 people
- Sponsor
- Mansoura University Hospital
Hemorrhage, Placenta Accreta Spectrum
Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD
The placenta accreta spectrum is a heterogeneous disorder due to abnormal placental invasion into the uterine wall putting at risk the lives of the patients by causing a massive hemorrhage.
- Conditions
- Hemorrhage, Placenta Accreta Spectrum, Cesarean Section Complications
- Trial name
- NCT06356493
- Testing
- caesarean hysterectomy with prior placement of prophylactic occlusion balloons of both internal iliac arteries, caesarean hysterectomy without prior placement of prophylactic occlusion balloons of both internal iliac arteries
- Where
- 2 sites in Tunisia
- Volunteers
- 38 people
- Sponsor
- Tunis University
Placenta Accreta Spectrum
Diagnostic Trial of a Vision Transformer-Based Ultrasound AI Model for Placenta Accreta Spectrum
This study develops an end-to-end Vision Transformer (ViT)-based artificial intelligence system for ultrasound-based diagnosis of placenta accreta spectrum (PAS), aiming to improve the accuracy and efficiency of prenatal…
- Trial name
- NCT07643090
- Testing
- Vision Transformer-Based End-to-End Ultrasound Artificial Intelligence Model
- Where
- China
- Volunteers
- 561 people
- Sponsor
- FANG HE
Placenta Accreta
Conservative Management for PAS Pilot
Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients.
- Trial name
- NCT05139498
- Testing
- Conservative management for placenta accreta spectrum (PAS), Cesarean hysterectomy for placenta accreta spectrum (PAS)
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- University of Utah
Placenta Accreta Spectrum, Placenta Previa
Maternal Serum Adropin in Placenta Accreta Spectrum
Aim: To compare maternal serum adropin levels in pregnancies complicated by placenta previa and/or placenta accreta spectrum (PAS) with those of healthy pregnant women and to evaluate the diagnostic value of adropin for…
- Trial name
- Adropin (NCT07421180)
- Where
- Turkey (Türkiye)
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Adana City Training and Research Hospital